Brookfield Renewable Partners 2020 Fourth Quarter Conference Call and Webcast for Investors and Analysts

Written by Customer Service on January 5, 2021. Posted in Public Companies.

Date: Thursday, February 4, 2021Time: 9:00 a.m. (Eastern Time)BROOKFIELD, News, Jan. 05, 2021 (GLOBE NEWSWIRE) — You are invited to participate in Brookfield Renewable Partners’ 2020 Fourth Quarter Conference Call and Webcast on Thursday, February 4, 2021 at 9:00 a.m. (Eastern Time) to discuss results and current business initiatives with members of senior management.These results will be released on Thursday, February 4, 2021 at approximately 7:00 a.m. and will be available on our website at http://bep.brookfield.com under “Press Releases”.To participate in the conference call, please dial 1-866-688-9430 toll-free at approximately 8:50 a.m. If calling from outside Canada or the U.S., dial 1-409-216-0817. When prompted, enter the conference ID, 4993154. The conference call will also be webcast live at https://edge.media-server.com/mmc/p/zrk38kj4,...

Euro Sun Appoints Peter Vukanovich Non-Executive Chair and Provides Rovina Valley Project Update

Written by Customer Service on January 5, 2021. Posted in Public Companies.

TORONTO, Jan. 05, 2021 (GLOBE NEWSWIRE) — Euro Sun Mining Inc. (TSX: ESM) (“Euro Sun” or the “Company”) is pleased to announce that the board of directors has elected Mr. Peter Vukanovich as non-executive chair of Euro Sun Mining. Mr. Vukanovich is an entrepreneurial leader and experienced corporate board member. He joined the ESM board of directors in July 2020. He currently leads PMV Consulting Inc., a company which provides advisory services to financial services and real estate technology clients. He is also on the Board of TSX listed Real Matters Inc.Mr. Vukanovich has held senior executive roles during his career including Genworth Financial Canada/GE Capital Mortgage Insurance, CFF Bank and Teranet Inc. He is a Chartered Professional Accountant, holds a Bachelor of Commerce degree from the University of Toronto and has...

Silvercorp Intersects a 1.58 Metre Interval Grading 17.08 g/t Gold, 301 g/t Silver and 18.66% Lead in a New Vein at the HPG Mine, Ying Mining District, China

Written by Customer Service on January 5, 2021. Posted in Public Companies.

VANCOUVER, British Columbia, Jan. 05, 2021 (GLOBE NEWSWIRE) — Silvercorp Metals Inc. (“Silvercorp” or the “Company”) (TSX/NYSE American: SVM) is pleased to report assay results from its 2020 exploration program at the HPG mine, Ying Mining District, Henan Province, China. In total, 13,515 metres (“m”) from 150 diamond drill holes, including 129 underground holes and 21 surface holes, have been completed from July 1, 2019 to October 31, 2020. Assay results for 140 holes have been received, with 69 holes intercepting mineralization. Nine rigs have been drilling at the HPG mine since July 2020. In addition to infill drill holes targeting areas of known sub-vertical silver-lead-zinc-gold veins previously believed to be uneconomic, the program discovered vein structures with relatively high gold, low silver-lead-zinc grade...

Constellation Brands Announces Full Redemption of 3.75% Senior Notes Due 2021

Written by Customer Service on January 5, 2021. Posted in Public Companies.

VICTOR, N.Y., Jan. 05, 2021 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, announced today that it has given notice for full redemption prior to maturity of all of its outstanding 3.75% Senior Notes due 2021 (CUSIP Number: 21036PAK4) (the “notes”) to be effected on February 4, 2021 (the “redemption date”). As of January 5, 2021, there were $500.0 million in aggregate principal amount of the notes outstanding.The redemption price for the notes, payable in cash, will be calculated pursuant to the formula set forth in the supplemental indenture relating to the notes, and will include a make-whole premium of approximately $4.0 million.ABOUT CONSTELLATION BRANDSConstellation Brands is an international producer and marketer of beer, wine and spirits with...

Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Written by Customer Service on January 5, 2021. Posted in Public Companies.

SAN DIEGO, Jan. 05, 2021 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections, today announced that the Compensation Committee of its Board of Directors granted a stock option to purchase 115,000 shares of its common stock to a new employee, pursuant to the Cidara Therapeutics, Inc. 2020 Inducement Incentive Plan, with a grant date of December 31, 2020. The stock option has an exercise price of $2.00 per share, which is equal to the closing price of Cidara’s common stock on the grant date. The shares subject to the option will vest over four years, with 25% of the shares vesting on the one-year anniversary of the vesting commencement date and the balance of the shares...

C4 Imaging Announces Sirius Positive Signal MRI Marker Given FDA 510(k) Clearance for Use with Isoray’s Cesium-131 Brachytherapy Seeds to Treat Prostate Cancer

Written by Customer Service on January 5, 2021. Posted in Public Companies.

HOUSTON, Texas, Jan. 05, 2021 (GLOBE NEWSWIRE) — C4 Imaging LLC is pleased to announce that Isoray Medical, Inc. (NYSE American: ISR) has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the use of C4 Imaging’s Sirius® positive-signal MRI (Magnetic Resonance Imaging) Markers with Isoray’s Cesium-131, brachytherapy seeds.Sirius is implanted during the treatment of prostate cancer with brachytherapy and is used to facilitate brachytherapy seed localization within the prostate utilizing a single post-implant MRI procedure. This allows the benefits of MRI assisted brachytherapy, also known as MRI assisted radiosurgery or MARS™, to be made available to all prostate cancer patients treated with brachytherapy.“This is a significant milestone,” said Andrew Bright, President and CEO of C4 Imaging. “Sirius MRI Markers will...

Rainmaker Worldwide Inc. Announces the Strengthening of its Team Following the Sale of its Water Subsidiary Rainmaker Holland BV to Sphere 3D Corp.

Written by Customer Service on January 5, 2021. Posted in Public Companies.

Peterborough, CA, Jan. 05, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Rainmaker Worldwide Inc. (OTC: RAKR) (“The Company”) announces it will continue to expand its focus on commercializing Environmental, Social and Governance (“ESG”) technologies following the completed sale of its water subsidiary Rainmaker Holland BV to Sphere 3D Corp. (NASDAQ: ANY) (“Sphere 3D”). The transaction is expected to close in less than 10 days. The acquisition was announced on January 4th and will transition the Rainmaker brand under Sphere 3D.RAKR will continue to pursue value creation for its shareholders by leveraging its institutional and market knowledge and asset base. RAKR will receive a percentage of gross revenue from all Rainmaker operations implemented in Jamaica over the next 4 years. RAKR plans to continue to build global joint venture...

Wolverine WorldWide Names Matt Blonder as President, Global eCommerce

Written by Customer Service on January 5, 2021. Posted in Public Companies.

ROCKFORD, Mich., Jan. 05, 2021 (GLOBE NEWSWIRE) — Wolverine World Wide, Inc. (NYSE: WWW), which operates one of the world’s largest portfolios of footwear and lifestyle brands, today announced the appointment of Matt Blonder as its new President, Global eCommerce. Blonder will report to Brendan Hoffman, Wolverine Worldwide’s President.Blonder brings to Wolverine Worldwide more than 20 years of omni-channel, consumer direct, digital marketing, and merchandising experience across a variety of well-known brands and retailers. Most recently, he was Global Head of Digital at Reebok, a division of Adidas, where he transformed the brand’s digital strategy, led a complete refresh of Reebok.com, revamped the digital consumer experience, and introduced a new global loyalty program.“Wolverine Worldwide witnessed a dramatic change in consumer...

Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2020 Revenues

Written by Customer Service on January 5, 2021. Posted in Public Companies.

TORONTO, Jan. 05, 2021 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced preliminary unaudited revenues for the fourth quarter and full year 2020. Profound is providing this information due to the significant lag time between planned investment community meetings to be held in connection with, among other investor events, the 39th Annual J.P. Morgan Healthcare Conference, and its expected reporting of final 2020 results in March 2021.Profound anticipates total revenues for the fourth quarter of 2020 to be approximately $3.7 million, representing growth of 32% year-over-year and 24% sequentially over the previous quarter. For the full year 2020,...

Athenex to Present at the 39th Annual J.P. Morgan Healthcare Conference

Written by Customer Service on January 5, 2021. Posted in Public Companies.

BUFFALO, N.Y., Jan. 05, 2021 (GLOBE NEWSWIRE) — Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, announced that it will participate in the 39th annual J. P. Morgan Healthcare Conference. Johnson Lau, CEO and Board Chairman, and Daniel Lang, Senior Director, Corporate Development, will present a corporate overview at the conference.When: Monday, January 11, 2021, at 8:40 AM ETWhere: Conference Virtual SessionA live audio webcast of the presentation and replay will be available in the “Events & Presentations” section of the Athenex website at https://ir.athenex.com/investor-calendar.About Athenex, Inc.Founded in 2003, Athenex, Inc. is a global clinical stage biopharmaceutical company...

Day: January 5, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice